Bruker Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BRKR research report →
Companywww.bruker.com
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits.
- CEO
- Frank H. Laukien
- IPO
- 2000
- Employees
- 11,396
- HQ
- Billerica, MA, US
Price Chart
Valuation
- Market Cap
- $6.74B
- P/E
- -580.72
- P/S
- 1.95
- P/B
- 2.75
- EV/EBITDA
- 26.08
- Div Yield
- 0.45%
Profitability
- Gross Margin
- 45.56%
- Op Margin
- 5.89%
- Net Margin
- -0.34%
- ROE
- -0.51%
- ROIC
- -2.92%
Growth & Income
- Revenue
- $3.44B · 2.08%
- Net Income
- $-8,600,000 · -107.60%
- EPS
- $-0.15 · -119.74%
- Op Income
- $236.00M
- FCF YoY
- -68.16%
Performance & Tape
- 52W High
- $56.22
- 52W Low
- $28.53
- 50D MA
- $37.94
- 200D MA
- $39.64
- Beta
- 1.12
- Avg Volume
- 2.15M
Get TickerSpark's AI analysis on BRKR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Bernard Thierry | other | 2,886 |
| May 15, 26 | Munch Mark | other | 2,000 |
| May 15, 26 | Munch Mark | sell | 2,000 |
| May 15, 26 | Munch Mark | other | 2,000 |
| Apr 15, 26 | Munch Mark | other | 2,000 |
| Apr 15, 26 | Munch Mark | sell | 2,000 |
| Apr 15, 26 | Munch Mark | other | 2,000 |
| Apr 1, 26 | Bernard Thierry | other | 0 |
| Mar 13, 26 | Munch Mark | other | 2,000 |
| Mar 13, 26 | Munch Mark | sell | 2,000 |
Our BRKR Coverage
We haven't published any research on BRKR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BRKR Report →